Navigation Links
Interventions needed to promote healthy behaviors among perinatally HIV-infected youth
Date:11/7/2012

As youth infected at birth with HIV reach adolescence and young adulthood, a new study published in Clinical Infectious Diseases underscores the need to promote healthy behaviors as some of these young people become sexually active.

Like other adolescents, some of the 330 young people in the study (from 15 sites across the U.S.) have initiated sexual activity, with many reporting having unprotected sex. Of the youth who were asked about disclosure of their HIV status to their first sexual partners, the majority reported that they had not disclosed to their partner prior to sexual activity, researchers found. While sexual activity is not uncommon among adolescents, HIV-infected or not, "HIV infection adds another level of complexity to the adolescence of youth who are infected and has implications for both their own health and that of their sexual partners," said lead study author Katherine Tassiopoulos, DSc, MPH, of the Harvard School of Public Health.

The link between not following regimens for antiretroviral therapy (ART) medications known as non-adherenceand risky sexual behaviors, already recognized among HIV-positive adults, is just now coming to light in adolescents as this cohort emerges from childhood. "Among youth, both non-adherence and sexual initiation may be expressions of independence or of the desire to feel accepted by peers," the authors noted. Successful interventions may account for adolescents' growing desire for independence by encouraging medication adherence, disclosure, and condom use as behaviors that will protect the health of their sexual partners as well as their own.

Early action by clinicians can help prepare these youth to make choices that reduce risk to themselves and to their partners. A critical step is informing youth of their HIV status. In this study, 18 percent of the participants were unaware they were HIV-positive at the time they started sexual activity. Clinicians and families should ensure that young people with HIV are informed of their HIV status prior to or during early adolescence, according to current guidelines for disclosure of HIV infection to children and adolescents.

Researchers found that among sexually active youth with high viral load (> 5,000 copies/ml), 81 percent had drug-resistant virus. This raises the possibility of resistant virus being transmitted to sexual partners and also limits treatment options for infected youth. Author George R. Seage III, DSc, MPH, also of the Harvard School of Public Health, believes that one critical step in encouraging optimal adherence may be informing young people "that ART can dramatically reduce the likelihood of sexual transmission of HIV."

Although the three-pronged messagesafer sex practices, disclosure of HIV status to sexual partners, and adherence to ART regimensis not new, targeted and innovative intervention strategies are needed to reach this important group of adolescents and reinforce healthy behaviors, the team of authors concluded.


'/>"/>

Contact: Jerica Pitts
jpitts@pcipr.com
312-558-1770
Infectious Diseases Society of America
Source:Eurekalert

Related medicine news :

1. Disorders of consciousness: How should clinicians respond to new therapeutic interventions?
2. Meta-analysis: Interventions improve depression in cancer patients
3. Health interventions for clergy must counteract need to put others first
4. Further steps needed to reduce stigma and expand access to substance abuse
5. For Mild Asthma, Daily Steroids May Not Be Needed, Study Says
6. Transformation of health system needed to improve care and reduce costs
7. New regulatory mechanism discovered in cell system for eliminating unneeded proteins
8. More Drug Trials Needed for Conditions Affecting Kids: Review
9. Many Teens With High Blood Pressure Dont Get Needed Tests
10. Study suggests changes in rotator cuff surgery rehabilitation needed
11. New technique could reduce number of animals needed to test chemical safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association ... Featuring a collection of specialty vendors and unique items from across the nation, this ... health and wellness services offered by the VNA. The boutique will be open ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: